Metastatic pancreatic ductal adenocarcinoma Trials in New York, United States
Conditions / Metastatic pancreatic ductal adenocarcinoma / New York, United States
Clinical trials for Metastatic pancreatic ductal adenocarcinoma investigate a range of treatment strategies and patient populations.
14 total trials for this combination
Showing top 10 of 14 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT06608927 | Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT05642962 | Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC) | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2 |
| NCT04150042 | SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells | RECRUITING | PHASE1 |
| NCT05685602 | CA-4948 Added to Standard Chemotherapy to Treat Metastatic or Unresectable Pancreatic Cancer | RECRUITING | — |
| NCT05685602 | CA-4948 Added to Standard Chemotherapy to Treat Metastatic or Unresectable Pancreatic Cancer | RECRUITING | — |
| NCT06445062 | Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors | RECRUITING | PHASE1/PHASE2 |
| NCT05630183 | A Study of Botensilimab in Participants With Metastatic Pancreatic Cancer | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT06917079 | BBO-11818 in Adult Subjects With KRAS Mutant Cancer | RECRUITING | PHASE1 |
| NCT04935359 | Study of Efficacy and Safety of NIS793 in Combination With Standard of Care (SOC) Chemotherapy in First-line Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) - daNIS-2 | COMPLETED | PHASE3 |
| NCT06168812 | A Study of Glipizide to Treat High Blood Sugar in People With Pancreatic Cancer | ACTIVE_NOT_RECRUITING | PHASE2 |